ZYLOX-TONBRDG.MED.TECH.H1 - Asset Resilience Ratio
ZYLOX-TONBRDG.MED.TECH.H1 (818) has an Asset Resilience Ratio of 32.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's Asset Resilience Ratio has changed over time. See ZYLOX-TONBRDG.MED.TECH.H1 (818) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down ZYLOX-TONBRDG.MED.TECH.H1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 818 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.15 Billion | 32.89% |
| Total Liquid Assets | €1.15 Billion | 32.89% |
Asset Resilience Insights
- Very High Liquidity: ZYLOX-TONBRDG.MED.TECH.H1 maintains exceptional liquid asset reserves at 32.89% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
ZYLOX-TONBRDG.MED.TECH.H1 Industry Peers by Asset Resilience Ratio
Compare ZYLOX-TONBRDG.MED.TECH.H1's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
APT Medical Inc
SHG:688617 |
Medical Devices | 8.63% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
Annual Asset Resilience Ratio for ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
The table below shows the annual Asset Resilience Ratio data for ZYLOX-TONBRDG.MED.TECH.H1.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.05% | €864.78 Million ≈ $1.01 Billion |
€3.45 Billion ≈ $4.04 Billion |
+12.48pp |
| 2023-12-31 | 12.57% | €424.29 Million ≈ $496.04 Million |
€3.38 Billion ≈ $3.95 Billion |
-7.57pp |
| 2022-12-31 | 20.14% | €655.37 Million ≈ $766.20 Million |
€3.25 Billion ≈ $3.80 Billion |
-26.36pp |
| 2021-12-31 | 46.50% | €1.51 Billion ≈ $1.77 Billion |
€3.25 Billion ≈ $3.80 Billion |
-- |
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and in… Read more